Curaleaf Holdings, Inc.
Close on Oct 19, 2026
- Market cap
- $2.07B
- P/E (TTM)
- –
- Dividend yield
- –
About Curaleaf
Medicinal Chemicals & Botanical Products, SIC 2833
Curaleaf Holdings, Inc. operates in the cannabis industry, producing and distributing cannabis and hemp products. The company functions primarily through two operating segments: a domestic segment and an international segment. Its primary commercial operations involve the cultivation, processing, and distribution of cannabis raw materials and finished goods, which generate revenue through retail dispensaries, wholesale transactions, and management services. Curaleaf serves retail consumers through its dispensary network, including adult-use customers, as well as wholesale clients and commercial partners.
The company maintains its principal executive offices in Vancouver, British Columbia, Canada, alongside corporate offices in Stamford, Connecticut. Curaleaf conducts business across North America and Europe, maintaining cultivation facilities, processing sites, and retail dispensaries. Its geographic reach includes operations across multiple United States jurisdictions, such as Arizona, Florida, Massachusetts, New Jersey, New York, and Pennsylvania, alongside international activities in Canada, Germany, Poland, and the United Kingdom.
Summary of the business section of Curaleaf's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Curaleaf Holdings, Inc.
- Headquarters
- Stamford, CT
- Address
- 250 Harbor Drive, Third Floor 06902
- Phone
- (917) 717-5875
- Industry
- Medicinal Chemicals & Botanical Products
- Incorporated in
- A1
- Fiscal year ends
- December 31
- Auditor
- PKF OConnor Davies, LLP, New York, New York
Stock & identifiers
- Ticker
- CURLF
- Exchange
- OTC
- Shares outstanding
- 265M, Jul 27, 2026
- Filer category
- Large accelerated filer
- Stock splits
- 1-for-3 reverse, Jun 5, 2026; 1-for-3 reverse, Jun 5, 2026
- SEC CIK
- 1756770
- CUSIP
- 23126M300
- ISIN
- US23126M3007
- LEI
- 529900UBH7GFAVEOKA76
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
Curaleaf's leadership is listed in its proxy statement (Form DEF 14A).